Weekly Administration of Brodalumab in Hidradenitis Suppurativa: An Open Label Cohort Study

Published: 20 June 2020| Version 2 | DOI: 10.17632/s3x24k6dky.2
Contributor:
John Frew

Description

Clinical Trial of Weekly Brodalumab in Hidradenitis Suppurativa

Files

Categories

Hidradenitis Suppurativa

Licence